Clinical and Histopathologic Evaluation of the Effect of 17-alpha-Hydroxyprogesterone-17-n-caproate*on Endometrial Carcinoma : Obstetrics & Gynecology

Secondary Logo

Journal Logo

Advanced Search
Clinical and Histopathologic Evaluation of the Effect of 17-alpha-Hydroxyprogesterone-17-n-caproate on Endometrial Carcinoma: PDF Only

Clinical and Histopathologic Evaluation of the Effect of 17-alpha-Hydroxyprogesterone-17-n-caproate*on Endometrial Carcinoma

VARGA, ALEXANDER M.D., F.A.C.O.G.; HENRIKSEN, ERLE M.D., F.A.C.O.G.

Author Information

Supported in part by a research grant from the Squibb Institute for Medical Research, and by National Cancer Institute Research Grant CY-5260 (C1).

Submitted for publication June 26, 1961.

Obstetrics & Gynecology 18(6):p 658-672, December 1961.
© 1961 The American College of Obstetricians and Gynecologists

Full Text Access for Subscribers:

Log in here >
ACOG Members, please click “Log in here” to access content
Log in here >

Not a Subscriber?

Buy
Request Permissions
Become a Society Member

You can read the full text of this article if you:

Access through Ovid